Evidence map›Paper›PMID 42627856›Full record

ArticlePLoS biology2026

Caveolin 1 is a conserved host factor mediating Bacillus cereus hemolysin BL toxin cytolytic toxicity.

Yingying Lu, Jie Liu, Chengyu Liu, Zehua Zuo, Michael Ewing, Hang Chen, Toren Finkel, Stephen H Leppla, Shihui Liu

Abstract read
In one paragraph

Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yingying LuAging Institute of University of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.
Jie LiuAging Institute of University of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.
Chengyu LiuTransgenic Core Facility, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Zehua ZuoAging Institute of University of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.
Michael EwingAging Institute of University of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.
Hang ChenAging Institute of University of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.
Toren FinkelAging Institute of University of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.
Stephen H LepplaMicrobial Pathogenesis Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Shihui LiuAging Institute of University of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.ORCID https://orcid.org/0000-0003-3444-1069

Funding

Vaccines and Therapeutics for AnthraxZIAAI000929 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LEPPLA, STEPHEN · 2009 to 2025
$15.9M
Defining cellular receptors for the Bacillus cereus hemolysin BL toxin (HBL) and the development of anti-HBL therapiesR01AI145879 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LIU, SHIHUI · 2020 to 2024
$2.5M
Mechanisms of anthrax lethal toxin-induced mortality and the novel biological-based targeted therapiesR01AI170574 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Shihui Liu · 2023 to 2026
$2.4M
Intramural NIH HHS ZIA AI000929NIAID NIH HHS R01 AI145879NIAID NIH HHS R01 AI170574
6 · The paper itself

Abstract

Hemolysin BL (HBL) is a tripartite α‑pore‑forming toxin and a major Bacillus cereus virulence factor. Although LITAF and its homolog CDIP1 were previously identified as host receptors that promote HBL‑induced cytolysis, mice lacking both proteins remain only partially protected, indicating the existence of additional determinants of susceptibility. Using genome‑wide CRISPR knockout screens in Litaf-/-/Cdip1-/- mouse embryonic fibroblasts and human HT1080 cells, we identify caveolin‑1 (CAV1), a caveola‑associated membrane protein, as a third conserved host factor required for HBL cytolytic activity. Confocal imaging and co‑immunoprecipitation analyses show that CAV1 colocalizes with HBL and physically associates with the toxin at the plasma membrane. Notably, mice lacking all three factors (Litaf/Cdip1/Cav1 triple knockouts) are completely resistant to HBL toxin challenge, establishing CAV1 as an additional host factor mediating HBL toxin cytotoxicity. These findings define a tripartite host factor system required for HBL toxin activity and position CAV1 as an additional host determinant to B. cereus virulence.

Indexed as

Bacillus cereusBacterial ProteinsBacterial ToxinsCaveolin 1Hemolysin ProteinsAnimalsCell MembraneFibroblastsHumansMiceMice, KnockoutVirulenceBacterial ProteinsBacterial ToxinsCaveolin 1hemolysin BL protein, BacillusHemolysin Proteins

Identifiers

PMID42627856
PMCPMC13524335

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.